ES2014060A6 - Procedimiento para la obtencion de productos farmaceuticos que actuan en particualr sobre el corazon y el sistema cardiovascular. - Google Patents

Procedimiento para la obtencion de productos farmaceuticos que actuan en particualr sobre el corazon y el sistema cardiovascular.

Info

Publication number
ES2014060A6
ES2014060A6 ES8901022A ES8901022A ES2014060A6 ES 2014060 A6 ES2014060 A6 ES 2014060A6 ES 8901022 A ES8901022 A ES 8901022A ES 8901022 A ES8901022 A ES 8901022A ES 2014060 A6 ES2014060 A6 ES 2014060A6
Authority
ES
Spain
Prior art keywords
heart
cardiovascular system
pharmaceutical compositions
procedure
compositions acting
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
ES8901022A
Other languages
English (en)
Spanish (es)
Inventor
Nagy Peter Literati
Nacida Hegeus Erzsebet Radvany
Maria Boros
Jeno Szilbereky
Gyorgy Blasko
Bela Gachalyi
Nacida Nemes Gizella Hamar
Gabor Nemeth
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BIOREX KFT
Original Assignee
BIOREX KFT
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by BIOREX KFT filed Critical BIOREX KFT
Publication of ES2014060A6 publication Critical patent/ES2014060A6/es
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A61K36/062—Ascomycota
    • A61K36/064—Saccharomycetales, e.g. baker's yeast
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Pain & Pain Management (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Molecular Biology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Reproductive Health (AREA)
  • Rheumatology (AREA)
  • Emergency Medicine (AREA)
  • Cardiology (AREA)
  • Obesity (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Neurology (AREA)
  • Urology & Nephrology (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
ES8901022A 1988-03-23 1989-03-21 Procedimiento para la obtencion de productos farmaceuticos que actuan en particualr sobre el corazon y el sistema cardiovascular. Expired - Fee Related ES2014060A6 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU881484A HU210122B (en) 1988-03-23 1988-03-23 Process for production of composition against thromboembolytic conditions of circulating system and heart

Publications (1)

Publication Number Publication Date
ES2014060A6 true ES2014060A6 (es) 1990-06-16

Family

ID=10954680

Family Applications (1)

Application Number Title Priority Date Filing Date
ES8901022A Expired - Fee Related ES2014060A6 (es) 1988-03-23 1989-03-21 Procedimiento para la obtencion de productos farmaceuticos que actuan en particualr sobre el corazon y el sistema cardiovascular.

Country Status (15)

Country Link
JP (1) JPH0222228A (enrdf_load_stackoverflow)
KR (1) KR890014104A (enrdf_load_stackoverflow)
BE (1) BE1003021A3 (enrdf_load_stackoverflow)
CA (1) CA1319607C (enrdf_load_stackoverflow)
CH (1) CH677732A5 (enrdf_load_stackoverflow)
DE (1) DE3909707A1 (enrdf_load_stackoverflow)
ES (1) ES2014060A6 (enrdf_load_stackoverflow)
FI (1) FI891438A7 (enrdf_load_stackoverflow)
FR (1) FR2628972B1 (enrdf_load_stackoverflow)
GB (1) GB2216421A (enrdf_load_stackoverflow)
HU (1) HU210122B (enrdf_load_stackoverflow)
IT (1) IT1229205B (enrdf_load_stackoverflow)
LU (1) LU87488A1 (enrdf_load_stackoverflow)
NL (1) NL8900742A (enrdf_load_stackoverflow)
SE (1) SE8901041L (enrdf_load_stackoverflow)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3114198B2 (ja) * 1990-11-06 2000-12-04 ソニー株式会社 電子機器
KR19990015198A (ko) * 1997-08-02 1999-03-05 손남율 식물성 항생제
BE1012495A3 (fr) 1999-03-02 2000-11-07 Messadek Jallal La glycine-betaine pour son usage antithrombotique.
US7608640B2 (en) 1999-03-02 2009-10-27 Jallal Messadek Glycine betaine and its use
GB2363331B (en) * 2000-06-17 2003-02-05 Raymond Clifford Noble Supplement to enhance fertility
FR2816211B1 (fr) * 2000-11-08 2005-04-01 Brif Nouvelles compositions dietetiques et ou/cosmetiques pour ameliorer la secheresse des muqueuses
BE1015608A6 (fr) 2003-07-15 2005-06-07 Messadek Jallal Traitement des arterites.
US8729124B2 (en) 2002-03-05 2014-05-20 Pronova Biopharma Norge As Use of EPA and DHA in secondary prevention
AU2003229993B2 (en) * 2002-05-03 2008-07-24 Pronova Biopharma Norge As Use of EPA and DHA in secondary prevention
US20040076695A1 (en) 2002-07-08 2004-04-22 Advanced Vision Research EPA and DHA enriched omega-3 supplement for the treatment of dry eye, meibomianitis and xerostomia
US20060233863A1 (en) 2003-02-10 2006-10-19 Enzymotec Ltd. Oils enriched with diacylglycerols and phytosterol esters and unit dosage forms thereof for use in therapy
FR2863170A1 (fr) * 2003-12-08 2005-06-10 Nicolai Christian Paul Xavier Composition regeneratrice et regulatrice de l'appareil digestif
BRPI0514244A (pt) * 2004-08-09 2008-06-03 Enzymotec Ltd produtos alimentìcios para diabéticos
EP1796726A2 (en) 2004-08-10 2007-06-20 Enzymotec Ltd. Mixture of phytosterol ester(s) and 1,3-diglyceride(s) for use in the treatment of medical conditions
WO2006050581A2 (en) 2004-11-10 2006-05-18 Jallal Messadek Betaine as agent against arthropod - or mosquito -borne diseases
HU227588B1 (hu) * 2004-12-03 2011-09-28 Sinnex Mueszaki Fejlesztoe Es Tanacsado Kft Többszörösen telítetlen zsírsavak észtereit tartalmazó vírusellenes és immunstimuláns gyógyászati készítmény
EP2242489A1 (en) 2005-02-15 2010-10-27 Jallal Messadek Combination therapeutic compositions and method of use
CA2650556A1 (en) 2005-04-27 2006-11-02 Jallal Messadek Insulins combinations
ITMI20052483A1 (it) * 2005-12-23 2007-06-24 Novamont Spa Esche biodegradabili
FR2935393B1 (fr) 2008-08-29 2012-08-24 Tetrahedron Bacteries et levures enrichies en selenium organique a partir de composes seleno-hydroxyacides et leurs applications en nutrition, cosmetique et pharmacie
FR2935394B1 (fr) 2008-08-29 2013-03-08 Eco Solution Microorganismes photosynthetiques enrichis en selenium organique a partir de composes seleno-hydroxyacides et leurs applications en nutrition, cosmetique et pharmacie

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1239587A (en) * 1983-10-24 1988-07-26 David Rubin Combined fatty acid composition for lowering blood cholestrol and triglyceride levels
HU202088B (en) * 1987-03-18 1991-02-28 Caola Kozmetikai Method for producing dietetic preparation
HU204199B (en) * 1987-03-18 1991-12-30 Caola Kozmetikai Process for producing pharmaceutical compositions containing unsaturated fatty acids and selenium as active components
HU209973B (en) * 1988-03-09 1995-01-30 Biorex Kutato Fejlesztoe Kft Process for production of antiviral and immunstimular pharmaceutical composition

Also Published As

Publication number Publication date
KR890014104A (ko) 1989-10-21
SE8901041D0 (sv) 1989-03-23
DE3909707A1 (de) 1989-10-05
IT8919876A0 (it) 1989-03-23
GB2216421A (en) 1989-10-11
GB8906856D0 (en) 1989-05-10
FI891438L (fi) 1989-09-24
HUT60436A (en) 1992-09-28
HU210122B (en) 1995-02-28
NL8900742A (nl) 1989-10-16
FR2628972A1 (fr) 1989-09-29
JPH0222228A (ja) 1990-01-25
CA1319607C (en) 1993-06-29
BE1003021A3 (fr) 1991-10-29
IT1229205B (it) 1991-07-25
LU87488A1 (fr) 1990-10-02
FR2628972B1 (fr) 1994-09-23
FI891438A7 (fi) 1989-09-24
CH677732A5 (enrdf_load_stackoverflow) 1991-06-28
FI891438A0 (fi) 1989-03-23
SE8901041L (sv) 1989-09-24

Similar Documents

Publication Publication Date Title
ES2014060A6 (es) Procedimiento para la obtencion de productos farmaceuticos que actuan en particualr sobre el corazon y el sistema cardiovascular.
AR240332A1 (es) Composiciones para facilitar la extraccion de articulos moldeados de poliables, composiciones de poliables que las contienen.
ES2053990T3 (es) Composiciones de acidos grasos esenciales.
ES551563A0 (es) Procedimiento para la preparacion de un suplemento mineral masticable
AR247660A1 (es) Una confitura complementada con minerales y su proceso de fabricacion
ES2057412T3 (es) Metodo para aumentar la salivacion en pacientes con xerostomia.
ATE129894T1 (de) Kurzbettige, einfach ungesättigte fettsäuren enthaltende nahrungsmittel und pharmazeutische zusammensetzungen sowie deren anwendungen.
ES2025766T3 (es) Un procedimiento para la preparacion de esteres de acidos grasos de polialcolholes.
ES518582A0 (es) Un procedimiento para preparar una composicion farmaceutica acuosa que contiene ubidecarenona.
MX9207494A (es) 4(5)-amino-1,8-naftiridinas substituidas, procedimiento para su preparacion y composiciones farmaceuticas que las contienen.
AR022358A1 (es) Una composicion de epo, un procedimiento para su obtencion, un preparado farmaceutico que la contiene y un procedimiento para aumentar la actividadespecifica de una composicion de epo
ES2009223A6 (es) Material antioxidante, procedimiento para prepararlo y composiciones cosmeticas y alimenticias que contienen dicho material.
ES2530510T3 (es) Constructos peptídicos sintéticos para el diagnóstico y tratamiento de periodontitis asociada con Porphyromonas gingivalis
ES2133655T3 (es) Aceites con bajo contenido de acidos grasos saturados.
ES511218A0 (es) "procedimiento para la preparacion de aditivos para piensos sobre la base de productos secundarios industriales de origen vegetal".
JPS5511573A (en) Novel naphthoquinones*their manufacture and medical composition containing them
ATE22532T1 (de) Pharmazeutische zusammensetzung.
ES2082843T3 (es) Composicion para productos de lavado, su procedimiento de preparacion y producto de lavado que la contiene.
ES2088780T3 (es) Complejos de inclusion con silibinina, su preparacion y composiciones farmaceuticas que los contienen.
ES2114532T3 (es) Producto de reposteria y procedimiento para mejorar la adherencia de recubrimientos basados en grasas a productos de reposteria congelados basados en grasas.
NO891220D0 (no) Middel som inneholder salicylsyre for behandling av lepidose.
ES2089210T3 (es) Nuevos compuestos de tipo graso solidos y no digestibles y composiciones alimenticias que los contienen.
ES2009248A6 (es) Composicion dietetica a base de algas que contengan selenio.
ES2081476T3 (es) Uso de acidos grasos especificos en la fabricacion de un medicamento para su suministro por iontoforesis.
AR013589A1 (es) Composicion para barra de jabon

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 19990405